DR PAUL ASHTON

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

EyePoint Pharmaceuticals, Inc.

Filing Date Source Excerpt
2008-05-02 Dr Ashton received a BSc (Hons) in chemistry from Durham University, England, and a PhD in pharmaceutical science from the University of Wales and is a visiting professor of Ophthalmology at the University of Kentucky.

Data sourced from SEC filings. Last updated: 2026-03-05